Temporary Occlusion and Therapeutic Delivery System
Legal Citation
Summary of the Inventive Concept
A novel embolic particle system for temporary occlusion of vascular defects, incorporating biodegradable materials, controlled release of therapeutic agents, and advanced delivery mechanisms to promote tissue healing and reduce inflammation.
Background and Problem Solved
The original patent describes embolic particles with a first diameter for delivery through a microcatheter and a second expanded diameter for occluding vascular defects. However, these particles may cause permanent occlusion, leading to potential complications. The new inventive concept addresses this limitation by introducing temporary occlusion and therapeutic delivery capabilities.
Detailed Description of the Inventive Concept
The system comprises embolic particles made of biodegradable materials that dissolve after a predetermined time period, allowing for temporary occlusion of vascular defects. The particles can be infused with therapeutic agents, which are released in a controlled manner to promote tissue healing and reduce inflammation. The system also includes advanced delivery mechanisms, such as a microcatheter with a specialized tip for precise navigation through tortuous vessels and a flow diverting stent to trap the embolic particles.
Novelty and Inventive Step
The new claims introduce the concept of temporary occlusion using biodegradable materials, controlled release of therapeutic agents, and advanced delivery mechanisms, which are not present in the original patent. These features provide a significant improvement over the existing technology.
Alternative Embodiments and Variations
Alternative embodiments may include different biodegradable materials, varying particle sizes, or different therapeutic agents. Additionally, the system could be adapted for use in other luminal defects, such as those in the bile ducts, urethra, or vagina.
Potential Commercial Applications and Market
The temporary occlusion and therapeutic delivery system has significant commercial potential in the medical device industry, particularly in the fields of interventional radiology and cardiology. The system's ability to promote tissue healing and reduce inflammation could lead to improved patient outcomes and reduced healthcare costs.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61L24/06 |
| A | A61 | A61L24/001 |
| C | C08 | C08F222/385 |
| A | A61 | A61L2430/36 |
Original Patent Information
| Patent Number | US 11,857,694 |
|---|---|
| Title | Particles |
| Assignee(s) | MicroVention, Inc. |